Skip to main content
Erschienen in: Inflammation 1/2017

24.11.2016 | ORIGINAL ARTICLE

The Spatio-Temporal Expression Profiles of CD4 + T Cell Differentiation and Function-Related Genes During EAE Pathogenesis

verfasst von: Yingying Cai, Hu Shen, Chaoyan Qin, Jinfeng Zhou, Weiming Lai, Juping Pan, Changsheng Du

Erschienen in: Inflammation | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Abstract

Multiple sclerosis is a CD4+ T cell-mediated autoimmune disease of the central nervous system. The unbalance of the cytokines and transcription factors critical for CD4+ T cell differentiation and function is probably the main reason that causes MS. We detected the mRNA expression changes of key cytokines and transcription factors which are critical for Th1, Th2, Th17, and Treg cell differentiation and function in different tissues during EAE pathogenesis. We fund that each gene not only has its own featured expression changes, but also has interaction with one another, which composes a network of immunity. Understanding the roles of key cytokines and transcription factors in these processes will help to understand disease pathogenesis and supply indications for disease therapy.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Lovett-Racke, A.E., Y. Yang, and M.K. Racke. 2011. Th1 versus Th17: Are T cell cytokines relevant in multiple sclerosis? Biochimica et Biophysica Acta 1812: 246–251.CrossRefPubMed Lovett-Racke, A.E., Y. Yang, and M.K. Racke. 2011. Th1 versus Th17: Are T cell cytokines relevant in multiple sclerosis? Biochimica et Biophysica Acta 1812: 246–251.CrossRefPubMed
3.
Zurück zum Zitat Kopf, M., G. Le Gros, M. Bachmann, M.C. Lamers, H. Bluethmann, and G. Kohler. 1993. Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature 362: 245–248.CrossRefPubMed Kopf, M., G. Le Gros, M. Bachmann, M.C. Lamers, H. Bluethmann, and G. Kohler. 1993. Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature 362: 245–248.CrossRefPubMed
4.
Zurück zum Zitat Kurata, H., H.J. Lee, A. O’Garra, and N. Arai. 1999. Ectopic expression of activated Stat6 induces the expression of Th2-specific cytokines and transcription factors in developing Th1 cells. Immunity 11: 677–688.CrossRefPubMed Kurata, H., H.J. Lee, A. O’Garra, and N. Arai. 1999. Ectopic expression of activated Stat6 induces the expression of Th2-specific cytokines and transcription factors in developing Th1 cells. Immunity 11: 677–688.CrossRefPubMed
5.
Zurück zum Zitat Gorelik, L., S. Constant, and R.A. Flavell. 2002. Mechanism of transforming growth factor beta-induced inhibition of T helper type 1 differentiation. Journal of Experimental Medicine 195: 1499–1505.CrossRefPubMedPubMedCentral Gorelik, L., S. Constant, and R.A. Flavell. 2002. Mechanism of transforming growth factor beta-induced inhibition of T helper type 1 differentiation. Journal of Experimental Medicine 195: 1499–1505.CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Veldhoen, M., R.J. Hocking, C.J. Atkins, R.M. Locksley, and B. Stockinger. 2006. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24: 179–189.CrossRefPubMed Veldhoen, M., R.J. Hocking, C.J. Atkins, R.M. Locksley, and B. Stockinger. 2006. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24: 179–189.CrossRefPubMed
7.
Zurück zum Zitat Ghilardi, N., and W. Ouyang. 2007. Targeting the development and effector functions of TH17 cells. Seminars in Immunology 19: 383–393.CrossRefPubMed Ghilardi, N., and W. Ouyang. 2007. Targeting the development and effector functions of TH17 cells. Seminars in Immunology 19: 383–393.CrossRefPubMed
8.
Zurück zum Zitat Reddy, J., Z. Illes, X. Zhang, J. Encinas, J. Pyrdol, L. Nicholson, R.A. Sobel, K.W. Wucherpfennig, and V.K. Kuchroo. 2004. Myelin proteolipid protein-specific CD4+CD25+ regulatory cells mediate genetic resistance to experimental autoimmune encephalomyelitis. Proceedings of the National Academy of Sciences of the United States of America 101: 15434–15439.CrossRefPubMedPubMedCentral Reddy, J., Z. Illes, X. Zhang, J. Encinas, J. Pyrdol, L. Nicholson, R.A. Sobel, K.W. Wucherpfennig, and V.K. Kuchroo. 2004. Myelin proteolipid protein-specific CD4+CD25+ regulatory cells mediate genetic resistance to experimental autoimmune encephalomyelitis. Proceedings of the National Academy of Sciences of the United States of America 101: 15434–15439.CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Horwitz, D.A., S.G. Zheng, and J.D. Gray. 2008. Natural and TGF-beta-induced Foxp3(+)CD4(+) CD25(+) regulatory T cells are not mirror images of each other. Trends in Immunology 29: 429–435.CrossRefPubMed Horwitz, D.A., S.G. Zheng, and J.D. Gray. 2008. Natural and TGF-beta-induced Foxp3(+)CD4(+) CD25(+) regulatory T cells are not mirror images of each other. Trends in Immunology 29: 429–435.CrossRefPubMed
10.
Zurück zum Zitat Yao, Y., W. Li, M.H. Kaplan, and C.H. Chang. 2005. Interleukin (IL)-4 inhibits IL-10 to promote IL-12 production by dendritic cells. Journal of Experimental Medicine 201: 1899–1903.CrossRefPubMedPubMedCentral Yao, Y., W. Li, M.H. Kaplan, and C.H. Chang. 2005. Interleukin (IL)-4 inhibits IL-10 to promote IL-12 production by dendritic cells. Journal of Experimental Medicine 201: 1899–1903.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Qian, X., L. Gu, H. Ning, Y. Zhang, E.C. Hsueh, M. Fu, X. Hu, L. Wei, D.F. Hoft, and J. Liu. 2013. Increased Th17 cells in the tumor microenvironment is mediated by IL-23 via tumor-secreted prostaglandin E2. Journal of Immunology 190: 5894–5902.CrossRef Qian, X., L. Gu, H. Ning, Y. Zhang, E.C. Hsueh, M. Fu, X. Hu, L. Wei, D.F. Hoft, and J. Liu. 2013. Increased Th17 cells in the tumor microenvironment is mediated by IL-23 via tumor-secreted prostaglandin E2. Journal of Immunology 190: 5894–5902.CrossRef
12.
Zurück zum Zitat Wang, L., C. Du, J. Lv, W. Wei, Y. Cui, and X. Xie. 2011. Antiasthmatic drugs targeting the cysteinyl leukotriene receptor 1 alleviate central nervous system inflammatory cell infiltration and pathogenesis of experimental autoimmune encephalomyelitis. Journal of Immunology 187: 2336–2345.CrossRef Wang, L., C. Du, J. Lv, W. Wei, Y. Cui, and X. Xie. 2011. Antiasthmatic drugs targeting the cysteinyl leukotriene receptor 1 alleviate central nervous system inflammatory cell infiltration and pathogenesis of experimental autoimmune encephalomyelitis. Journal of Immunology 187: 2336–2345.CrossRef
13.
Zurück zum Zitat Krakowski, M., and T. Owens. 1996. Interferon-gamma confers resistance to experimental allergic encephalomyelitis. European Journal of Immunology 26: 1641–1646.CrossRefPubMed Krakowski, M., and T. Owens. 1996. Interferon-gamma confers resistance to experimental allergic encephalomyelitis. European Journal of Immunology 26: 1641–1646.CrossRefPubMed
14.
Zurück zum Zitat Smits, H.H., J.G. van Rietschoten, C.M. Hilkens, R. Sayilir, F. Stiekema, M.L. Kapsenberg, and E.A. Wierenga. 2001. IL-12-induced reversal of human Th2 cells is accompanied by full restoration of IL-12 responsiveness and loss of GATA-3 expression. European Journal of Immunology 31: 1055–1065.CrossRefPubMed Smits, H.H., J.G. van Rietschoten, C.M. Hilkens, R. Sayilir, F. Stiekema, M.L. Kapsenberg, and E.A. Wierenga. 2001. IL-12-induced reversal of human Th2 cells is accompanied by full restoration of IL-12 responsiveness and loss of GATA-3 expression. European Journal of Immunology 31: 1055–1065.CrossRefPubMed
15.
Zurück zum Zitat Leonard, J.P., K.E. Waldburger, and S.J. Goldman. 1995. Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12. Journal of Experimental Medicine 181: 381–386.CrossRefPubMed Leonard, J.P., K.E. Waldburger, and S.J. Goldman. 1995. Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12. Journal of Experimental Medicine 181: 381–386.CrossRefPubMed
16.
Zurück zum Zitat Schiering, C., T. Krausgruber, A. Chomka, A. Frohlich, K. Adelmann, E.A. Wohlfert, J. Pott, T. Griseri, J. Bollrath, A.N. Hegazy, O.J. Harrison, B.M. Owens, M. Lohning, Y. Belkaid, P.G. Fallon, and F. Powrie. 2014. The alarmin IL-33 promotes regulatory T-cell function in the intestine. Nature 513: 564–568.CrossRefPubMedPubMedCentral Schiering, C., T. Krausgruber, A. Chomka, A. Frohlich, K. Adelmann, E.A. Wohlfert, J. Pott, T. Griseri, J. Bollrath, A.N. Hegazy, O.J. Harrison, B.M. Owens, M. Lohning, Y. Belkaid, P.G. Fallon, and F. Powrie. 2014. The alarmin IL-33 promotes regulatory T-cell function in the intestine. Nature 513: 564–568.CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Kassiotis, G., and G. Kollias. 2001. Uncoupling the proinflammatory from the immunosuppressive properties of tumor necrosis factor (TNF) at the p55 TNF receptor level: implications for pathogenesis and therapy of autoimmune demyelination. Journal of Experimental Medicine 193: 427–434.CrossRefPubMedPubMedCentral Kassiotis, G., and G. Kollias. 2001. Uncoupling the proinflammatory from the immunosuppressive properties of tumor necrosis factor (TNF) at the p55 TNF receptor level: implications for pathogenesis and therapy of autoimmune demyelination. Journal of Experimental Medicine 193: 427–434.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Wohlfert, E.A., J.R. Grainger, N. Bouladoux, J.E. Konkel, G. Oldenhove, C.H. Ribeiro, J.A. Hall, R. Yagi, S. Naik, R. Bhairavabhotla, W.E. Paul, R. Bosselut, G. Wei, K. Zhao, M. Oukka, J. Zhu, and Y. Belkaid. 2011. GATA3 controls Foxp3(+) regulatory T cell fate during inflammation in mice. Journal of Clinical Investigation 121: 4503–4515.CrossRefPubMedPubMedCentral Wohlfert, E.A., J.R. Grainger, N. Bouladoux, J.E. Konkel, G. Oldenhove, C.H. Ribeiro, J.A. Hall, R. Yagi, S. Naik, R. Bhairavabhotla, W.E. Paul, R. Bosselut, G. Wei, K. Zhao, M. Oukka, J. Zhu, and Y. Belkaid. 2011. GATA3 controls Foxp3(+) regulatory T cell fate during inflammation in mice. Journal of Clinical Investigation 121: 4503–4515.CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Ponomarev, E.D., K. Maresz, Y. Tan, and B.N. Dittel. 2007. CNS-derived interleukin-4 is essential for the regulation of autoimmune inflammation and induces a state of alternative activation in microglial cells. Journal of Neuroscience 27: 10714–10721.CrossRefPubMed Ponomarev, E.D., K. Maresz, Y. Tan, and B.N. Dittel. 2007. CNS-derived interleukin-4 is essential for the regulation of autoimmune inflammation and induces a state of alternative activation in microglial cells. Journal of Neuroscience 27: 10714–10721.CrossRefPubMed
20.
Zurück zum Zitat Zhou, L., J.E. Lopes, M.M. Chong, I.I. Ivanov, R. Min, G.D. Victora, Y. Shen, J. Du, Y.P. Rubtsov, A.Y. Rudensky, S.F. Ziegler, and D.R. Littman. 2008. TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature 453: 236–240.CrossRefPubMedPubMedCentral Zhou, L., J.E. Lopes, M.M. Chong, I.I. Ivanov, R. Min, G.D. Victora, Y. Shen, J. Du, Y.P. Rubtsov, A.Y. Rudensky, S.F. Ziegler, and D.R. Littman. 2008. TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature 453: 236–240.CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Dhib-Jalbut, S., H. Jiang, and G.J. Williams. 1996. The effect of interferon beta-1b on lymphocyte-endothelial cell adhesion. Journal of Neuroimmunology 71: 215–222.CrossRefPubMed Dhib-Jalbut, S., H. Jiang, and G.J. Williams. 1996. The effect of interferon beta-1b on lymphocyte-endothelial cell adhesion. Journal of Neuroimmunology 71: 215–222.CrossRefPubMed
22.
Zurück zum Zitat Maimone, D., G.C. Guazzi, and P. Annunziata. 1997. IL-6 detection in multiple sclerosis brain. Journal of Neurological Sciences 146: 59–65.CrossRef Maimone, D., G.C. Guazzi, and P. Annunziata. 1997. IL-6 detection in multiple sclerosis brain. Journal of Neurological Sciences 146: 59–65.CrossRef
23.
Zurück zum Zitat McGeachy, M.J., K.S. Bak-Jensen, Y. Chen, C.M. Tato, W. Blumenschein, T. McClanahan, and D.J. Cua. 2007. TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nature Immunology 8: 1390–1397.CrossRefPubMed McGeachy, M.J., K.S. Bak-Jensen, Y. Chen, C.M. Tato, W. Blumenschein, T. McClanahan, and D.J. Cua. 2007. TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nature Immunology 8: 1390–1397.CrossRefPubMed
24.
Zurück zum Zitat Zhou, L., I.I. Ivanov, R. Spolski, R. Min, K. Shenderov, T. Egawa, D.E. Levy, W.J. Leonard, and D.R. Littman. 2007. IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nature Immunology 8: 967–974.CrossRefPubMed Zhou, L., I.I. Ivanov, R. Spolski, R. Min, K. Shenderov, T. Egawa, D.E. Levy, W.J. Leonard, and D.R. Littman. 2007. IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nature Immunology 8: 967–974.CrossRefPubMed
25.
Zurück zum Zitat Kebir, H., K. Kreymborg, I. Ifergan, A. Dodelet-Devillers, R. Cayrol, M. Bernard, F. Giuliani, N. Arbour, B. Becher, and A. Prat. 2007. Human TH17 lymphocytes promote blood–brain barrier disruption and central nervous system inflammation. Nature Medicine 13: 1173–1175.CrossRefPubMedPubMedCentral Kebir, H., K. Kreymborg, I. Ifergan, A. Dodelet-Devillers, R. Cayrol, M. Bernard, F. Giuliani, N. Arbour, B. Becher, and A. Prat. 2007. Human TH17 lymphocytes promote blood–brain barrier disruption and central nervous system inflammation. Nature Medicine 13: 1173–1175.CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Cua, D.J., J. Sherlock, Y. Chen, C.A. Murphy, B. Joyce, B. Seymour, L. Lucian, W. To, S. Kwan, T. Churakova, S. Zurawski, M. Wiekowski, S.A. Lira, D. Gorman, R.A. Kastelein, and J.D. Sedgwick. 2003. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421: 744–748.CrossRefPubMed Cua, D.J., J. Sherlock, Y. Chen, C.A. Murphy, B. Joyce, B. Seymour, L. Lucian, W. To, S. Kwan, T. Churakova, S. Zurawski, M. Wiekowski, S.A. Lira, D. Gorman, R.A. Kastelein, and J.D. Sedgwick. 2003. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421: 744–748.CrossRefPubMed
27.
Zurück zum Zitat McGeachy, M.J., Y. Chen, C.M. Tato, A. Laurence, B. Joyce-Shaikh, W.M. Blumenschein, T.K. McClanahan, J.J. O’Shea, and D.J. Cua. 2009. The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo. Nature Immunology 10: 314–324.CrossRefPubMedPubMedCentral McGeachy, M.J., Y. Chen, C.M. Tato, A. Laurence, B. Joyce-Shaikh, W.M. Blumenschein, T.K. McClanahan, J.J. O’Shea, and D.J. Cua. 2009. The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo. Nature Immunology 10: 314–324.CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Fontenot, J.D., M.A. Gavin, and A.Y. Rudensky. 2003. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nature Immunology 4: 330–336.CrossRefPubMed Fontenot, J.D., M.A. Gavin, and A.Y. Rudensky. 2003. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nature Immunology 4: 330–336.CrossRefPubMed
29.
Zurück zum Zitat Marie, J.C., J.J. Letterio, M. Gavin, and A.Y. Rudensky. 2005. TGF-beta1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells. Journal of Experimental Medicine 201: 1061–1067.CrossRefPubMedPubMedCentral Marie, J.C., J.J. Letterio, M. Gavin, and A.Y. Rudensky. 2005. TGF-beta1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells. Journal of Experimental Medicine 201: 1061–1067.CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Rollnik, J.D., E. Sindern, C. Schweppe, and J.P. Malin. 1997. Biologically active TGF-beta 1 is increased in cerebrospinal fluid while it is reduced in serum in multiple sclerosis patients. Acta Neurologica Scandinavica 96: 101–105.CrossRefPubMed Rollnik, J.D., E. Sindern, C. Schweppe, and J.P. Malin. 1997. Biologically active TGF-beta 1 is increased in cerebrospinal fluid while it is reduced in serum in multiple sclerosis patients. Acta Neurologica Scandinavica 96: 101–105.CrossRefPubMed
31.
Zurück zum Zitat Lalive, P.H., R. Paglinawan, G. Biollaz, E.A. Kappos, D.P. Leone, U. Malipiero, J.B. Relvas, M. Moransard, T. Suter, and A. Fontana. 2005. TGF-beta-treated microglia induce oligodendrocyte precursor cell chemotaxis through the HGF-c-Met pathway. European Journal of Immunology 35: 727–737.CrossRefPubMed Lalive, P.H., R. Paglinawan, G. Biollaz, E.A. Kappos, D.P. Leone, U. Malipiero, J.B. Relvas, M. Moransard, T. Suter, and A. Fontana. 2005. TGF-beta-treated microglia induce oligodendrocyte precursor cell chemotaxis through the HGF-c-Met pathway. European Journal of Immunology 35: 727–737.CrossRefPubMed
32.
Zurück zum Zitat Chaudhry, A., R.M. Samstein, P. Treuting, Y. Liang, M.C. Pils, J.M. Heinrich, R.S. Jack, F.T. Wunderlich, J.C. Bruning, W. Muller, and A.Y. Rudensky. 2011. Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation. Immunity 34: 566–578.CrossRefPubMedPubMedCentral Chaudhry, A., R.M. Samstein, P. Treuting, Y. Liang, M.C. Pils, J.M. Heinrich, R.S. Jack, F.T. Wunderlich, J.C. Bruning, W. Muller, and A.Y. Rudensky. 2011. Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation. Immunity 34: 566–578.CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat Bettelli, E., M.P. Das, E.D. Howard, H.L. Weiner, R.A. Sobel, and V.K. Kuchroo. 1998. IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice. Journal of Immunology 161: 3299–3306. Bettelli, E., M.P. Das, E.D. Howard, H.L. Weiner, R.A. Sobel, and V.K. Kuchroo. 1998. IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice. Journal of Immunology 161: 3299–3306.
Metadaten
Titel
The Spatio-Temporal Expression Profiles of CD4 + T Cell Differentiation and Function-Related Genes During EAE Pathogenesis
verfasst von
Yingying Cai
Hu Shen
Chaoyan Qin
Jinfeng Zhou
Weiming Lai
Juping Pan
Changsheng Du
Publikationsdatum
24.11.2016
Verlag
Springer US
Erschienen in
Inflammation / Ausgabe 1/2017
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-016-0469-1

Weitere Artikel der Ausgabe 1/2017

Inflammation 1/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.